Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT03844594
Eligibility Criteria:
Inclusion Criteria:
1. Age≥18 years.
2. Acute ischemic stroke.
3. Treated with endovascular treatment, including intra-arterial thrombolysis, mechanical thrombectomy, and angioplasty.
4. Written informed consent obtained from patient or patient's legally authorized representative.
Exclusion Criteria:
1. Failed to vascular recanalization (mTICI≤1).
2. Diagnosis of intracranial hemorrhagic disease, such as intracranial hemorrhage, subarachnoid hemorrhage and so on.
3. Known coagulopathy, Systemic Bleeding Tendency, or baseline platelet count \< 100000/mm3.
4. History of chronic hepatopathy, liver and kidney dysfunction, elevating ALT (\> 3 times normal upper limit), elevating serum creatinine (\> 2 times normal upper limit).
5. Patients with severe hypertension (systolic blood pressure \> 200mmHg or diastolic blood pressure \> 110mmHg).
6. Known drug or food allergy.
7. Used other Glycoprotein IIb/IIIa receptor antagonists.
8. Contraindications for DSA, severe contrast media allergy or iodine contrast media absolute contraindications.
9. Childbearing age women whose pregnancy tests were negative refused to take effective contraception. Pregnant or lactating or positive pregnancy test on admission.
10. Incapable to follow this study for mental illness, cognitive or emotional disorder.
11. The researchers do not consider the participants appropriate to get into this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03844594
Study Brief:
Protocol Section:
NCT03844594